Abbott Molecular Inc 1300 E Touhy Avedes Plaines Il 60018 Pma Numberp200013 Supplement Numbers009 Date Received09 21 2022 Decision Date10 24 2022 Product Code Mkt Advisory Committee Microbiology Supplement Typespecial Immediate Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Abbott Molecular Inc 1300 E Touhy Avedes Plaines Il 60018 Pma Numberp200013 Supplement Numbers009 Date Received09 21 2022 Decision Date10 24 2022 Product Code Mkt Advisory Committee Microbiology Supplement Typespecial Immediate Track Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P200013S009 Abbott Molecular, Inc.1300 E Touhy Avedes Plaines, IL 60018 PMA NumberP200013 Supplement NumberS009 Date Received09/21/2022 Decision Date10/24/2022 Product Code MKT  Advisory Committee Microbiology Supplement Typespecial (immediate Track) Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No	Alinity m HBV	2022-10-24